10 min listen
Episode 2: Cell-penetrating peptides for cancer treatment
FromA view on
ratings:
Length:
9 minutes
Released:
Jun 28, 2020
Format:
Podcast episode
Description
One of the limitations of cancer therapy is off-target activity, which often has devastating effects on patients’ life quality. A novel strategy pursued by Cybrexa Therapeutics uses treatments specifically targeting solid tumors by taking advantage of one of their universal biomarkers – acidity. By using cell-penetrating peptides bearing an anticancer cargo load, their platform brings the treatment directly inside tumors, leaving healthy cells alone and minimizing bystander killings.
Released:
Jun 28, 2020
Format:
Podcast episode
Titles in the series (32)
Episode 3: Mesenchymal stem cells for COVID-19 treatment: Mesoblast CEO Dr. Silviu Itescu speaks to Lonza about the company’s advanced portfolio of anti-inflammatory allogeneic cellular medicines including remestemcel-L, which is currently being evaluated in a U.S. Phase 3 randomized controlled trial for acute ... by A view on